ABACUS MEDICINE A/S: Financial statements 2016
CVR: 28111576
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ABACUS MEDICINE A/S (CVR 28111576) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 1,320,154,000 and a net result of DKK 28,655,000 compared with DKK 17,815,000 the year before. That is an increase of 58% compared with the year before. The profit margin was 2.2%. Equity in the 2016 report amounted to DKK 70,680,000. The solvency ratio was 28.2%. The company had 67 employees in the financial year.
- Revenue
- DKK 1,320,154,000
- Gross Profit
- DKK 96,883,000
- Profit/Loss
- DKK 28,655,000
- Equity
- DKK 70,680,000
- Total Assets
- DKK 250,896,000
- Employees
- 67
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 1.3 mia. | 96.9 mio. | 28.7 mio. | 70.7 mio. | 67 |
| 2015 | 835.5 mio. | 61.8 mio. | 17.8 mio. | 61.7 mio. | 46 |
| 2014 | 625.2 mio. | 56.4 mio. | 13.2 mio. | 24.4 mio. | 39 |
| 2013 | 489.5 mio. | 35.7 mio. | 5.7 mio. | 6.1 mio. | 40 |
Official annual report
Find more companies like ABACUS MEDICINE A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
ABACUS MEDICINE A/S has published its annual report for 2015. Revenue came to DKK 835,482,000, and the net result was DKK 17,815,000.
About ABACUS MEDICINE A/S
ABACUS MEDICINE A/S is a Danish company of the type Aktieselskab based in København V, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ABACUS MEDICINE ApS. The management consists of Flemming Wagner. The board consists of Jens Albert Harsaae (chair), Alette Margaretha Verbeek, Anders Kunze Bønding and Flemming Wagner. The company is owned by Wagner Family Holding ApS and CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB. The company has 388 employees (2026). In 2025, the company reported revenue of EUR 1,817,637,000 and a net result of EUR 7,779,000 compared with EUR 17,621,000 the year before. Equity in the 2025 report amounted to EUR 98,523,000.